🇺🇸 FDA
Patent

US 12186363

Compositions and methods for dengue virus chimeric constructions in vaccines

granted A61KA61K2039/5254A61K2039/70

Quick answer

US patent 12186363 (Compositions and methods for dengue virus chimeric constructions in vaccines) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/5254, A61K2039/70, A61K31/7048, A61K31/713